References
1. Farman, M., et al. . Fractal-fractional operator for COVID-19 (Omicron) variant outbreak with analysis and modeling. RESULTS PHYS 39, 105630 (2022).
2. Franch-Llasat, D., et al. . Pneumococcal meningitis secondary to otitis media in two patients with COVID-19 omicron variant. INT J EMERG MED 15, 50 (2022).
3. Galloway, S., Taunton, C., Matysek, R. & Hempenstall, A. Seeking to improve access to COVID-19 therapeutics in the remote Torres and Cape communities of Far North Queensland during the first COVID-19 omicron outbreak. RURAL REMOTE HEALTH 22, 7657 (2022).
4. Jing, Y., et al. . Potential influence of COVID-19/ACE2 on the female reproductive system. MOL HUM REPROD 26, 367-373 (2020).
5. South, A.M., Diz, D.I. & Chappell, M.C. COVID-19, ACE2, and the cardiovascular consequences. AM J PHYSIOL-HEART C 318, H1084-H1090 (2020).
6. Sui, P., et al. . Pulmonary neuroendocrine cells amplify allergic asthma responses. SCIENCE 360(2018).
7. Carvelli, J., et al. . Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. NATURE 588, 146-150 (2020).
8. Lamb, L.E., et al. . COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC). MED HYPOTHESES 145, 110375 (2020).
9. Fernandez-Cruz, A., et al. . A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.ANTIMICROB AGENTS CH 64(2020).
10. Jiao, X., et al. . A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities. CLIN TRANSL MED 10, e235 (2020).
11. Thye, A.Y., et al. . Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19.BIOLOGY-BASEL 11(2022).
12. Martinez-Gomez, L.E., et al. . ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men. FRONT IMMUNOL 13, 812940 (2022).
13. Khan, W.H., et al. . COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions. FRONT CELL INFECT MI 11, 690621 (2021).
14. Huang, B., et al. . Substance P protects against hyperoxic-induced lung injury in neonatal rats. EXP LUNG RES 41, 12-20 (2015).
15. Wang, N., et al. . Substance P-induced lung inflammation in mice is mast cell dependent. CLIN EXP ALLERGY 52, 46-58 (2022).
16. Lieb, K., et al. . Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men.NEUROPSYCHOPHARMACOL 27, 1041-1049 (2002).
17. Piedimonte, G. Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. AM J RESP CRIT CARE 163, S18-S21 (2001).